Skip to content
Screener

Everspin Technologies MRAM Product sales — Total Revenue

Other product segments

Engineering services and other revenue
$3.28M
Royalties
$139K-57.2%
Licensing
$0-100%

Similar metrics at other companies

Travere Therapeutics, Inc. logo
TVTXTotal net product sales — Total Revenue
$124.49M+64.1%
Moderna logo
MRNANet product sales — Total Revenue
$352M+309%
CorMedix logo
CRMDProduct sales, net — Total Revenue
$121.92M+212%
Teradata logo
TDCProduct Sales — Total Revenue
$371M+3.9%
PTH
PTHSNet product revenues — Total Revenue
$10.67M
Illumina logo
ILMNTotal product revenue — Total Revenue
$982M+7.7%

Other financials

Income statement

See full
Revenue$18.7M+41.9%
Gross profit$10.1M+49.2%
Operating income-$4.4M-124%
Net income-$3.6M-436%
EPS (diluted)-$0.15-400%

Balance sheet

See full
Cash & equivalents$43.9M-2.4%
Total debt$905.0K-66.2%
Total equity$73.1M+14.1%
Total assets$89.4M+13.3%

Cash flow

See full
Operating cash flow$159.0K-96.8%
CapEx$1.3M-33.5%
Free cash flow-$1.2M-138%

Valuation

See full
Market cap$405.18M+201%
Enterprise value$362.19M+293%
P/S6.5×+3.9×

Profitability

See full
Gross margin52.3%+1.4pp
Operating margin-15.5%+1.0pp
Net margin-1.1%-3.9pp
FCF margin11.5%+4.7pp

Returns & leverage

See full
Return on equity-0.9%-3.7pp
Debt / equity0.0×
Current ratio4.7×-1.1×

Where this comes from

Reported directly by Everspin Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Everspin Technologies’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053558
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Product sales$15,313$11,091$29,413$22,117
Licensing, royalty, engineering services and other revenue3,4232,1104,1954,222
Total revenue18,73613,20133,60826,339
Cost of product sales8,2966,16615,25112,195
Cost of licensing, royalty, engineering services and other revenue343267417623
Total cost of sales8,6396,43315,66812,818
Gross profit10,0976,76817,94013,521
Operating expenses:

Item 1. Financial Statements

FAQ

What is Everspin Technologies's product sales — total revenue?
Everspin Technologies (MRAM) reported product sales — total revenue of $15.31M in Q2 2026.
How has Everspin Technologies's product sales — total revenue changed year-over-year?
Everspin Technologies's product sales — total revenue increased by 38.1% year-over-year, from $11.09M to $15.31M.
What is the long-term trend for Everspin Technologies's product sales — total revenue?
Over 4 years (2021 to 2025), Everspin Technologies's product sales — total revenue has grown at a 2.4% compound annual growth rate (CAGR), from $43.93M to $48.29M.
What does product sales — total revenue mean?
This metric represents the total gross income generated from the sale of physical hardware units or proprietary memory products within the company's primary business segment. It serves as a key indicator of market demand for the company's core technology offerings and reflects the scale of commercial adoption for its specific product portfolio. Growth in this figure highlights the company's ability to successfully monetize its technological innovations and expand its footprint in the semiconductor market.

Ask your AI about Everspin Technologies's product sales — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude